The Time Machine episode artwork

EPISODE · Jul 28, 2025 · 39 MIN

The Time Machine

from In the Interim... · host Berry

Dr. Scott Berry and Dr. Kert Viele discuss the origins and implementation of the “time machine” modeling approach, beginning with sports analytics and progressing to adaptive platform clinical trials. The episode focuses on how techniques for comparing athletes across eras translate into methodology for platform trials. Key HighlightsSports analytics as foundation: Early work of modelling athlete comparisons across eras using bridging methodologies.Platform trial application: The time machine model in I-SPY 2 enabled efficient control allocation through overlapping arms over extended trial periods.Core modeling principles: Additive treatment effect assumptions and the necessity of sufficient temporal overlap for reliable era comparisons.Statistical implementation: Approaches include categorical era adjustment and Bayesian smoothing splines for modeling change over time.Limitations and disease specificity: In conditions with rapid clinical or epidemiologic change, such as COVID-19, non-concurrent controls are avoided due to high risk of era by treatment interaction.Regulatory and methodological distinction: The model leverages within-trial overlapping data collected under a unified protocol, contrasting sharply with external or historical controls.

Episode metadata supplied by the publisher feed · Published Jul 28, 2025

Dr. Scott Berry and Dr. Kert Viele discuss the origins and implementation of the “time machine” modeling approach, beginning with sports analytics and progressing to adaptive platform clinical trials. The episode focuses on how techniques for comparing athletes across eras translate into methodology for platform trials. Key HighlightsSports analytics as foundation: Early work of modelling athlete comparisons across eras using bridging methodologies.Platform trial application: The time machine model in I-SPY 2 enabled efficient control allocation through overlapping arms over extended trial periods.Core modeling principles: Additive treatment effect assumptions and the necessity of sufficient temporal overlap for reliable era comparisons.Statistical implementation: Approaches include categorical era adjustment and Bayesian smoothing splines for modeling change over time.Limitations and disease specificity: In conditions with rapid clinical or epidemiologic change, such as COVID-19, non-concurrent controls are avoided due to high risk of era by treatment interaction.Regulatory and methodological distinction: The model leverages within-trial overlapping data collected under a unified protocol, contrasting sharply with external or historical controls.

PodParley-generated summary based on available episode metadata and transcript content.

NOW PLAYING

The Time Machine

0:00 39:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of In the Interim...?

This episode is 39 minutes long.

When was this In the Interim... episode published?

This episode was published on July 28, 2025.

What is this episode about?

Dr. Scott Berry and Dr. Kert Viele discuss the origins and implementation of the “time machine” modeling approach, beginning with sports analytics and progressing to adaptive platform clinical trials. The episode focuses on how techniques for...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this In the Interim... episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!